Lucira Health Inc Revenue per Employee (LHDX), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Lucira Health Inc   (NASDAQ: LHDX)
 

Lucira Health Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 157.53% in the third quarter 2022, year on year to cumulative value of $212 million, Lucira Health Inc 's revenue per employee grew on a trailing twelve months basis to $ 2,123,170, this marks a new company high.
Within the Healthcare sector Employees of 23 other companies have achieved higher revenue per employee. While Lucira Health Inc 's total ranking has deteriorated compared to the previous quarter from 0 to 345. Lucira Health Inc has 100 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

LHDX Revenue per Employee (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter		 (Sep 30 2021)
III. Quarter
Y / Y Revenue Change 157.53 % 110.19 % 1903.41 % 22690.71 % -
Sales per Employee (TTM) $ 2,123,170 1,912,810 1,775,740 916,160 305,780
LHDX's Total Ranking # 345 # 0 # 0 # 0 # 0
Seq. Revenue Change 31.53 % -71.1 % 47.58 % 359.09 % 7.36 %

LHDX Company Profile >> Back to LHDX Efficiency Comparisons >> Compare LHDX Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
In Vitro & In Vivo Diagnostic Substances Industry # 8
Healthcare Sector # 24
Overall Market # 345

Revenue per Employee Statistics
High Average Low
$ 2,123,170 $ 1,681,970 $ 916,160
(Sep 30 2022)   (Dec 31 2021)



Financial Statements
Lucira Health Inc 's Revenue MRQ $ 34 Millions Visit LHDX's Income Statement
Lucira Health Inc 's Revenues TTM $ 212 Millions Visit LHDX's aggregate revenue growth
What are LHDX's Sales? Visit LHDX's Sales by Segment




Other Ratios
Lucira Health Inc 's Income per Employee
Employees in In Vitro & In Vivo Diagnostic Substances
In Vitro & In Vivo Diagnostic Substances Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
LHDX's Revenue per Employee versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for LHDX's Competitors
Revenue per Employee for LHDX's Suppliers
Revenue per Employee for LHDX's Customers

You may also want to know
LHDX's Sales Growth Rates LHDX's Pe Price to earnings ratio LHDX's Receivables Turnover Ratio LHDX's Stock Quote
LHDX's Net Income Growth Rates LHDX's Ps Price to Sales ratio LHDX's Sales per Employee LHDX's Asset Turnover Ratio
LHDX's Net Margin LHDX's Pb Price to Book ratio LHDX's Financial Strength Ratios LHDX's Dividend Payout Ratio
Date modified: 2026-08-29T17:43:19+00:00




Companies with similar Revenue per Employee for 12 months ending Sep 30 2022, within Healthcare Sector Revenue per Employee Revenue 12 months ending Sep 30 2022Number of Employees Sep 30 2022
Illumina Inc   3,671,093.75 $ 4,699.000  Million 1,280 
Tvardi Therapeutics Inc   3,285,583.33 $ 39.427  Million 12 
Agilon Health Inc   2,898,741.82 $ 2,481.323  Million 856 
Iteos Therapeutics Inc   2,893,178.34 $ 454.229  Million 157 
Xoma Royalty Corporation  2,891,785.71 $ 40.485  Million 14 
Horizon Therapeutics Public Limited Company  2,847,291.54 $ 3,701.479  Million 1,300 
Akumin Inc   2,788,161.05 $ 744.439  Million 267 
Barinthus Biotherapeutics Plc  2,731,785.71 $ 38.245  Million 14 
Lannett Company Inc  2,697,741.38 $ 312.938  Million 116 
Dynavax Technologies Corporation  2,662,767.27 $ 732.261  Million 275 
Assertio Holdings inc   2,626,622.64 $ 139.211  Million 53 
Eagle Pharmaceuticals inc   2,548,982.91 $ 298.231  Million 117 
Novavax inc   2,465,518.02 $ 1,846.673  Million 749 
Pulmatrix Inc   2,409,500.00 $ 4.819  Million 2 
Morphic Holding inc   2,394,516.13 $ 74.230  Million 31 
Innoviva Inc   2,347,270.44 $ 373.216  Million 159 
Sunwin Stevia International Inc.  2,124,881.13 $ 33.998  Million 16 
Maravai Lifesciences Holdings Inc   2,084,441.38 $ 906.732  Million 435 
Imagenebio Inc   2,025,600.00 $ 30.384  Million 15 
Amgen Inc   2,025,384.62 $ 26,330.000  Million 13,000 
Sorrento Therapeutics Inc   2,010,733.33 $ 60.322  Million 30 
Veru Inc   1,967,717.60 $ 39.354  Million 20 
Prestige Consumer Healthcare Inc   1,943,400.00 $ 1,107.738  Million 570 
Kala Bio inc   1,916,000.00 $ 5.748  Million 3 
Arbutus Biopharma Corp  1,893,684.21 $ 35.980  Million 19 
Elutia Inc   1,822,423.08 $ 47.383  Million 26 
Semler Scientific inc   1,755,903.23 $ 54.433  Million 31 
Shockwave Medical Inc   1,699,169.96 $ 429.890  Million 253 
Emergent Biosolutions Inc   1,692,333.33 $ 1,523.100  Million 900 
Synlogic Inc   1,666,000.00 $ 1.666  Million 1 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.